Financial Forensics Proof of Concept
Demonstration output: five-year financial pattern review and example diligence questions · 2021–2025
Proof of concept — demonstration
This document is a proof-of-concept demonstration of a financial analysis workflow. It is published to illustrate the methodology, structure, and potential usefulness of the output.
It is not a production analyst report, investment research, investment advice, a recommendation, an offer, or a solicitation to buy, sell, hold, or subscribe for any security or financial instrument.
The analysis is based solely on publicly available financial data and source materials reviewed for this demonstration. It does not rely on inside information, confidential company information, or non-public management materials.
Findings should be treated as analytical hypotheses and example management questions, not conclusions of fact. The report may contain errors, omissions, or interpretations that require further verification against primary source materials. It should not be relied upon as the sole basis for any investment, credit, or commercial decision. No representation or warranty is made as to the completeness, accuracy, or timeliness of the information. The author accepts no responsibility for any loss arising from reliance on this material.
The most significant patterns identified across five years of financial data and three years of CEO disclosures.
SG&A cost growth has scaled proportionally with revenue rather than decelerating, and operating margin has not returned to its 2021 baseline despite the business reaching $5,200m in revenue. The FY2025 CEO letter names a fiscal 2027 non-GAAP operating margin target as a live commitment, confirming management is aware that margin improvement has not yet materialised.
Operating margin deteriorated from 6.8% in 2021 to -2.5% in 2025 — a 9.3-percentage-point deterioration endpoint to endpoint. SG&A ended the period at 33.9% of revenue, above the 32.3% recorded in 2021 — the only year in the series at which positive operating margin was achieved — and has been flat since 2023 rather than declining. The FY2023 CEO letter describes this cost structure as reflecting "trademark GTM efficiency"; the financial series does not yet confirm that characterisation. The 2023 trough of -9.8% appears linked to isolated exceptional items, but the normalised series also shows no return to breakeven. R&D is not separately disclosed; without a disclosed R&D line it is not possible to determine whether cost growth is concentrated in growth-generative investment or in overhead expected to scale sub-linearly — a distinction that is directly material to evaluating whether the operating leverage thesis remains intact. The fiscal 2027 non-GAAP target does not resolve when or whether GAAP operating breakeven occurs, and the gap between the two measures widened to 3.5% of revenue in 2025.
At $5,200m in revenue, SG&A that has not deleveraged in two years raises a material question over whether cost behaviour will reset at scale, or whether the fiscal 2027 non-GAAP target will be reached without a corresponding improvement in GAAP operating margin.
The FY2024 CEO letter confirms the acquisition of Loom during fiscal 2024. The financial series reflects this: goodwill rose $562m to $1,289m, intangibles rose $230m to $299m, and other investing outflows increased $956m to -$931m — all in the same year. The balance sheet now carries a materially higher acquired-asset base relative to the pre-acquisition position.
The Loom acquisition was completed while operating margin remained negative and the business was simultaneously accelerating buybacks. Goodwill as a percentage of assets rose from 17.7% in 2023 to 24.7% in 2024 before partially retracing to 21.6% in 2025. The recoverability of the $1,289m goodwill balance is conditioned on Loom meeting acquisition-case revenue and integration assumptions; goodwill impairment testing schedules in the primary filings would confirm whether any indicators have been assessed. If Loom's revenue contribution is responsible for a meaningful share of the FY2024 step-up from $3,500m to $4,400m, the organic growth rate implied by the headline series may be lower than reported figures suggest — a distinction that narrows the window in which scale-driven margin improvement could plausibly occur.
An acquisition of this scale, undertaken without operating profitability in the acquiring business, compounds the existing margin deficit with integration execution risk; the goodwill impairment exposure introduced by the $562m step-up is directly conditioned on acquisition-case assumptions that the financial series alone cannot verify.
OCF grew from $790m to $1,500m across a period in which net income remained negative in every year, ranging from approximately -$579m to -$257m. The two series point in opposite directions of magnitude, creating a bifurcated picture of financial performance depending on which measure is used.
The OCF-to-net-income ratio is not interpretable for any year due to negative denominators. The FY2025 CEO letter headlines business performance with $1,400m in free cash flow while making no reference to GAAP earnings or operating margin — a pattern consistent across all three years of CEO letters reviewed. This decoupling is consistent with large non-cash charges — stock-based compensation and amortisation of acquired intangibles — and deferred revenue dynamics, though the FY2025 shift from OCF to FCF as the CEO's headline cash metric is itself a disclosure observation: the two metrics converge in 2024–2025 at $1,400m, suggesting CapEx is minimal, but the change in chosen metric warrants clarification. Primary-source cash flow statement disaggregation would confirm how much of the OCF improvement reflects genuine cash economics versus accounting structure.
A GAAP-earnings-based assessment characterises the business as deeply loss-making at -4.9% net margin in 2025; the cash series at $1,500m OCF characterises it as strongly generative — an assessor relying on one series without the other risks a materially incomplete view of financial health.
Buybacks accelerated from zero in 2022 to $779m in 2025 — a cumulative $1,324m over three years — while operating margin remained negative in every year and the business carried a recently expanded acquisition-phase balance sheet following the Loom transaction. The FY2025 CEO letter makes no reference to the buyback programme, capital return policy, or OCF coverage thresholds.
Buybacks at $779m represent approximately 52% of 2025 OCF of $1,500m. The $384m year-on-year acceleration from 2024 to 2025 is observable in the series. One reading is that this pace reflects management confidence in OCF durability, consistent with the FY2025 reported cloud net revenue retention rate of 120%; the competing reading is that simultaneous pursuit of acquisitions, buybacks, and organic investment without operating profitability compresses financial flexibility across all three capital uses. Interest coverage was -2× in both 2024 and 2025. Board-level authorisation rationale and any stated OCF coverage policy are not visible in the financial series.
Any deceleration in OCF growth — whether from revenue slowdown, Loom integration costs, or step-up in organic investment — would create immediate tension between the buyback programme and balance sheet flexibility, at a pace of capital return that is not yet anchored to a disclosed coverage framework.
======================================================================
Five-year series · USD millions unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | Direction |
|---|---|---|---|---|---|---|
| Revenue (USDm) | 2,100 | 2,800 | 3,500 | 4,400 | 5,200 | ↑ improvement |
| Gross margin (%) | 84.1 | 83.8 | 82.3 | 81.6 | 82.8 | → indeterminate |
| Operating margin (%) | 6.8 | 2.5 | -9.8 | -2.7 | -2.5 | ↓ deterioration |
| Net margin (reported) (%) | -27.7 | -18.6 | -13.8 | -6.9 | -4.9 | ↑ improvement |
| Net margin (normalised) (%) | -23.2 | -14.8 | -8.1 | -5.4 | -1.4 | ↑ improvement |
| Reported-vs-normalised gap (%) | -4.5 | -3.8 | -5.7 | -1.5 | -3.5 | context-dependent |
| SG&A as % of revenue (%) | 32.3 | 34.9 | 37.4 | 33.9 | 33.9 | ↓ deterioration |
| CapEx as % of revenue (%) | 1.6 | 2.7 | 0.7 | 0.8 | 0.9 | context-dependent |
| Operating cash flow (USDm) | 790 | 821 | 868 | 1,400 | 1,500 | ↑ improvement |
| Free cash flow (USDm) | 757 | 746 | 842 | 1,400 | 1,400 | ↑ improvement |
| Net cash / (debt) (USDm) | 622 | 460 | 1,100 | 1,400 | 1,900 | ↑ improvement |
| Return on equity (%) | -196.3 | -159 | -74.4 | -29.1 | -19.1 | ↑ improvement |
| Current ratio (×) | 1 | 1 | 1 | 1 | 1 | context-dependent |
| Goodwill as % of assets (%) | 24.6 | 21.7 | 17.7 | 24.7 | 21.6 | context-dependent |
| Intangibles as % of assets (%) | 4.2 | 3 | 1.7 | 5.7 | 4 | context-dependent |
| Interest coverage (×) | 22 | 5 | -12 | -2 | -2 | ↓ deterioration |
| EBITDA (USDm) | 197 | 122 | -284 | -38 | -38 | ↓ deterioration |
| DSO (days) | 33 | 40 | 49 | 53 | 54 | ↓ deterioration |
Areas where the financial data and CEO disclosures together leave material questions unanswered.
Five years of revenue growth have not restored operating margin, which remains negative at period-end despite the business reaching $5,200m in scale. Revenue grew 149.6% over five years; operating margin deteriorated from 6.8% in 2021 to -2.5% in 2025, a deterioration of 9.3 percentage points endpoint to endpoint. SG&A as a percentage of revenue ended 1.6 points higher than it started and has been flat since 2023. The 2023 trough of -9.8% appears linked to isolated exceptional items, but the normalised series also shows no operating breakeven. The FY2024 revenue step-up from $3,500m to $4,400m is the largest single-year absolute increase in the series and coincides with the confirmed Loom acquisition; if a meaningful share of that step-up is Loom-derived, organic growth may be decelerating faster than headline figures indicate, narrowing the window in which scale-driven margin improvement could plausibly occur. At $5,200m in revenue, the absence of operating leverage raises a material question over whether the conventional SaaS operating leverage thesis applies to this business's cost structure in its current form.
Evidence: Revenue grew 149.6% over five years; operating margin deteriorated from 6.8% in 2021 to -2.5% in 2025, a deterioration of 9.3 percentage points endpoint to endpoint. SG&A as a percentage of revenue ended 1.6 points higher than it started. The 2023 trough of -9.8% appears linked to isolated exceptional items, but the pre-exceptional normalised series also shows no operating breakeven. If the 2024 revenue step-up is partly acquisition-derived, organic growth may be decelerating faster than headline figures indicate, narrowing the window in which scale-driven margin improvement could plausibly occur.
Why it matters: At $5,200 in revenue, the absence of operating leverage is a structural signal — not merely a size-maturity question — that challenges the conventional SaaS operating leverage thesis for this business.
The Loom acquisition was completed in fiscal 2024 while operating margin remained negative, and the goodwill recoverability introduced by the transaction cannot be assessed from the financial series alone. Goodwill rose $562m to $1,289m in 2024; intangibles rose $230m to $299m; other investing outflows increased $956m to -$931m in the same year. These movements are confirmed by the FY2024 CEO letter as reflecting the Loom acquisition. Deal consideration, revenue attribution, and integration KPIs are not visible in the financial series. An acquisition of this magnitude, undertaken without operating profitability in the acquiring business, adds integration execution risk as a compounding factor to the existing margin deficit. The $562m goodwill step-up introduces impairment exposure that is conditioned on Loom meeting acquisition-case assumptions; primary-source goodwill impairment testing disclosures would confirm whether any indicators have been identified.
Evidence: Goodwill rose $562 to $1,289 in 2024; intangibles rose $230 to $299; other investing outflows increased $956 to -$931 in the same year. These three signals in a single year exceed the threshold for coincidental organic movement and are consistent with material inorganic activity.
Why it matters: An acquisition of this magnitude, undertaken while the core business has not reached operating breakeven, adds integration execution risk as a direct compounding factor to the existing margin deficit. If integration absorbs management bandwidth or generates incremental costs, the path to operating profitability becomes longer — and the goodwill impairment risk introduced by the $562 step-up is directly conditioned on the acquired entity meeting acquisition-case assumptions that cannot be verified from the available financial data.
The gap between reported and normalised net margin has been present in every year of the series and widened in 2025 relative to 2024. Gap by year: 2021: 4.5% | 2022: 3.8% | 2023: 5.7% | 2024: 1.5% | 2025: 3.5%. The 2023 peak carries an isolated exceptional items classification in the source data; the gaps in 2021, 2022, and 2025 carry no equivalent classification, leaving their recurring versus non-recurring status unresolved. The FY2025 CEO letter references a fiscal 2027 non-GAAP operating margin target, which is constructed on the normalised basis — meaning the 3.5% gap between reported and normalised is embedded in the target metric. If the gap in 2025 reflects stock-based compensation or recurring items rather than genuinely isolated events, the normalised series may be overstating the improvement in underlying profitability, and the fiscal 2027 non-GAAP target may not correspond to a recovery in GAAP operating margin on a comparable timeline.
Evidence: Gap by year: 2021: 4.5% | 2022: 3.8% | 2023: 5.7% | 2024: 1.5% | 2025: 3.5%. The 2023 peak is classified as isolated exceptional items in the source data; the gaps in 2021, 2022, and 2025 carry no equivalent classification, making their recurring versus non-recurring status unresolved.
Why it matters: If the gap reflects stock-based compensation or recurring restructuring rather than genuinely isolated items, the normalised series may be overstating the true improvement in underlying profitability.
DSO has expanded by 21 days across the full series, and receivables grew at more than twice the rate of revenue in two consecutive years. Receivables growth exceeded revenue growth by approximately 1.8× in 2021–2022 and 2.1× in 2022–2023; DSO moved from 33 days in 2021 to 54 days in 2025. The trend has stabilised but not reversed. The FY2025 CEO letter reports a record number of deals over $1m in annual contract value — more than 1.5× the prior year total — which is consistent with payment terms on larger enterprise contracts extending DSO, though the financial series alone cannot confirm this as the mechanism. Sustained DSO expansion in a subscription-heavy software business is atypical; the evidence does not resolve whether this reflects a deliberate mix shift toward longer-dated enterprise contracts, a change in collection performance within cohorts, or revenue recognition timing shifts — each carrying different credit implications.
Evidence: Receivables growth exceeded revenue growth by approximately 1.8× in 2021–2022 and 2.1× in 2022–2023; DSO moved from 33 days in 2021 to 54 days in 2025. The trend has stabilised but not reversed.
Why it matters: Sustained DSO expansion in a subscription-heavy software business is atypical and may indicate a structural mix shift toward longer-dated enterprise contracts, deteriorating collection performance, or revenue recognition timing changes — each with different credit implications.
Buybacks have accelerated to 52% of OCF while the business carries negative operating margin and integration risk from the Loom acquisition. Buybacks: 2023: $150m | 2024: $395m | 2025: $779m; operating margin remained negative in all three years; interest coverage was -2× in 2024 and 2025. OCF reached $1,500m in 2025, providing observable cash coverage. The $384m year-on-year acceleration from 2024 to 2025 is the fastest single-year increase in the series. One interpretation is that the pace reflects management confidence in OCF sustainability, supported by the FY2025 disclosed cloud net revenue retention rate of 120%; the competing interpretation is that the pace is not yet consistent with a business still carrying Loom integration risk and an unresolved operating leverage deficit. The board's OCF coverage threshold and capital return policy are not disclosed in the available materials. The pace of buyback acceleration raises a board-level capital allocation governance question that the financial series cannot resolve without a disclosed coverage framework and explicit prioritisation between the three concurrent capital uses. ======================================================================
Evidence: Buybacks: 2023: $150 | 2024: $395 | 2025: $779; operating margin remained negative in all three years; interest coverage was -2× in 2024 and 2025. OCF is strongly positive at $1,500 in 2025, and buybacks at $779 represent approximately 52% of 2025 OCF — an observable coverage ratio visible in the series. One interpretation is that buyback acceleration reflects management confidence in OCF sustainability and signals that the business is approaching a capital return phase; the competing interpretation is that the pace is inconsistent with a business still carrying integration risk and an unresolved operating leverage deficit. Both interpretations require management's explicit capital allocation framework to resolve.
Why it matters: The pace of buyback acceleration ($384 increase year-on-year from 2024 to 2025) is inconsistent with a business still in the investment phase of its operating leverage journey and raises a board-level capital allocation governance question.
These questions are residualised — confirmed management disclosures have been incorporated into findings above; each question targets only what remains unresolved. Each question corresponds to the tension of the same number.
Operating margin deteriorated from 6.8% in 2021 to -2.5% in 2025 despite 149.6% revenue growth — what specific cost categories are expected to scale as a fixed base as revenue grows, and what revenue level does management consider necessary to return to positive operating margin, given that SG&A has not meaningfully deleveraged since 2023?
Can management confirm the nature, total consideration, and revenue contribution of the 2024 investing event — and what is the timeline and KPI basis for assessing whether the acquired assets are performing to acquisition-case assumptions?
What are the specific components driving the reported-versus-normalised gap in 2025, and does management classify any portion of the 3.5% gap as recurring — in particular, stock-based compensation treatment in the normalisation methodology?
Has the DSO expansion from 33 days in 2021 to 54 days in 2025 been driven by a deliberate enterprise-contract mix shift with correspondingly higher contract values, or does management observe any change in collection performance within cohorts — and is the receivables balance subject to any concentration that would affect collectibility assessment?
Buybacks accelerated from $395 in 2024 to $779 in 2025 — representing approximately 52% of 2025 OCF — while operating margin remained negative at -2.5%; what is the board's stated OCF coverage threshold at which the current buyback pace would be suspended, and how does that threshold interact with potential integration costs from the 2024 acquisition event and the requirements of any ongoing organic investment programme?
Accepted changes incorporated; no material unresolved reviewer disputes.
This document is a proof-of-concept demonstration of a financial analysis workflow. It is published to illustrate the methodology, structure, and potential usefulness of the output.
It is not a production analyst report, investment research, investment advice, a recommendation, an offer, or a solicitation to buy, sell, hold, or subscribe for any security or financial instrument.
The analysis is based solely on publicly available financial data and source materials reviewed for this demonstration. It does not rely on inside information, confidential company information, or non-public management materials. It may not include all public filings, accounting notes, management commentary, market data, or subsequent events.
Findings should be treated as analytical hypotheses and example management questions, not conclusions of fact. The report may contain errors, omissions, or interpretations that require further verification against primary source materials. It should not be relied upon as the sole basis for any investment, credit, or commercial decision.
No representation or warranty is made as to the completeness, accuracy, or timeliness of the information contained in this report. The author accepts no responsibility for any loss arising from reliance on this material.